Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study.

Literature DB >> 28005279

Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study.

A M Tobin¹, M Sadlier¹, P Collins², S Rogers², O FitzGerald³, B Kirby².

Abstract

Entities: Disease

Mesh：

Year: 2017 PMID： 28005279 DOI： 10.1111/bjd.15258

Source DB: PubMed Journal: Br J Dermatol ISSN： 0007-0963 Impact factor: 9.302

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network.

Authors: Mehmet Tuncay Duruöz; Halise Hande Gezer; Kemal Nas; Erkan Kilic; Betül Sargin; Sevtap Acer Kasman; Hakan Alkan; Nilay Sahin; Gizem Cengiz; Nihan Cuzdan; İlknur Albayrak Gezer; Dilek Keskin; Cevriye Mulkoglu; Hatice Resorlu; Sebnem Ataman; Ajda Bal; Okan Kucukakkas; Ozan Volkan Yurdakul; Meltem Alkan Melikoglu; Fikriye Figen Ayhan; Merve Baykul; Hatice Bodur; Mustafa Calis; Erhan Capkin; Gul Devrimsel; Kevser Gök; Sami Hizmetli; Ayhan Kamanlı; Yaşar Keskin; Hilal Ecesoy; Öznur Kutluk; Nesrin Sen; Ömer Faruk Sendur; İbrahim Tekeoglu; Sena Tolu; Murat Toprak; Tiraje Tuncer
Journal: Rheumatol Int Date: 2020-06-20 Impact factor: 2.631

2. Prevalence and variables associated with fatigue in psoriatic arthritis: a cross-sectional study.

Authors: Joel Shi Quan Tan; Warren Fong; Yu Heng Kwan; Ying Ying Leung
Journal: Rheumatol Int Date: 2020-08-09 Impact factor: 2.631

3. Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies.

Authors: Christopher T Ritchlin; Philip J Mease; Wolf-Henning Boehncke; John Tesser; Elena Schiopu; Soumya D Chakravarty; Alexa P Kollmeier; Xie L Xu; May Shawi; Yusang Jiang; Shihong Sheng; Yanli Wang; Stephen Xu; Joseph F Merola; Iain B McInnes; Atul Deodhar
Journal: RMD Open Date: 2022-03

4. Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.

Authors: Proton Rahman; Philip J Mease; Philip S Helliwell; Atul Deodhar; Laure Gossec; Arthur Kavanaugh; Alexa P Kollmeier; Elizabeth C Hsia; Bei Zhou; Xiwu Lin; May Shawi; Chetan S Karyekar; Chenglong Han
Journal: Arthritis Res Ther Date: 2021-07-14 Impact factor: 5.156

Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study.

1. The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network.

2. Prevalence and variables associated with fatigue in psoriatic arthritis: a cross-sectional study.

3. Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies.

4. Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.

5. Prevalence and Characterization of Fatigue in Patients with Skin Diseases.

Review 6. Fatigue - an underestimated symptom in psoriatic arthritis.

7. Prevalence and severity of fatigue in psoriasis and psoriatic arthritis.